SOBRsafe Receives $2.8 Million in Gross Proceeds from Exercise of Warrants, Also Fully Converts All Notes Payable into Common Equity
Rhea-AI Summary
SOBRsafe, a provider of next-generation transdermal alcohol detection solutions, announced it has received $2.8 million in gross proceeds from the exercise of warrants. This financial move also included converting $2.6 million in debt into 4,358,957 shares of common stock, significantly strengthening its balance sheet.
The transactions were made possible through an inducement letter, where the warrant holder agreed to convert all warrants at a reduced exercise price of $0.27 per share. This conversion involved 10,319,163 warrants. The underlying shares are eligible for resale under Rule 144 or have been registered for resale through Form S-1 registration statements. Concurrently, SOBRsafe issued the holder 20,638,326 new warrants, also exercisable at $0.27 per share.
These actions are part of SOBRsafe's strategy to build financial flexibility and regain Nasdaq listing compliance, positioning the company for accelerated growth.
Positive
- Received $2.8 million in gross proceeds from warrant exercises.
- Converted $2.6 million in debt into 4,358,957 shares of common stock.
- Strengthened balance sheet by reducing debt and increasing equity.
- Enhanced financial flexibility for future growth.
- Steps taken to regain Nasdaq listing compliance.
Negative
- Issued 20,638,326 new warrants, potentially diluting existing shareholders.
- Reduced exercise price of $0.27 per share may lower the perceived value of shares.
- Conversion of debt to equity could indicate challenges in meeting debt obligations.
News Market Reaction – SOBR
On the day this news was published, SOBR declined 3.73%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
The Company Strengthens Balance Sheet, Takes Strides to Regaining Nasdaq Listing Compliance
DENVER, CO / ACCESSWIRE / June 6, 2024 / SOBR Safe, Inc. (NASDAQ:SOBR) ("SOBRsafe" or "the Company"), provider of next-generation transdermal alcohol detection solutions, announced today that it has received approximately
SOBRsafe has also settled its remaining debt balances through the conversion of outstanding Notes Payable into 4,358,957 shares of Common Stock.
"These are very positive developments for the future of SOBRsafe," affirmed CEO & Chairman Dave Gandini. "We have significantly strengthened our balance sheet with both this infusion of capital and elimination of
Warrant Inducement Transaction
On June 4, 2024, the Company entered into an inducement offer letter agreement (the "Inducement Letter") with the holder (the "Holder") of the Company's warrants issued pursuant to the Amended and Restated Common Stock Purchase Warrants, with an initial exercise date of September 27, 2021, dated September 30, 2022, the Amended and Restated Common Stock Purchase Warrants, with an initial exercise date of March 30, 2022, dated September 30, 2022 and warrants issued to the Holder under the Waiver agreement dated March 30, 2022, (collectively, the "Applicable Warrants").
Pursuant to the Inducement Letter, the Holder agreed to convert all the Applicable Warrants at a reduced exercise price equal to
The shares of common stock of the Company underlying the Applicable Warrants (the "Warrant Shares") are eligible for resale pursuant to Rule 144 of the Securities Act or have been registered for resale pursuant to registration statements on Form S-1 (File No. 333-267882) (File No. 333-262665) (the "Registration Statements"). The Registration Statements are currently effective and, upon exercise of the Applicable Warrants will be effective for the resale of the Warrant Shares.
In exchange for the transactions contemplated hereunder, the Company shall concurrently issue the Holder 20,638,326 new warrants (the "New Warrant") to subscribe for and purchase from the Company 20,638,326 shares (the "New Warrant Shares"). The New Warrant exercise price shall be
This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
---
About SOBRsafe™
Alcohol misuse is the fourth leading cause of preventable death in America, and the seventh worldwide. Yet prevention and monitoring solutions have not kept pace with this epidemic. Legacy technologies are invasive and inefficient, unhygienic, and unconnected. There has to be a better way.
Enter SOBRsafe™. Our advanced transdermal (touch-based) technology detects and instantaneously reports the presence of alcohol as emitted through a user's skin - no breath, blood or urine sample is required. With a powerful backend data platform, SOBRsafe provides next generation, passive detection technology for the behavioral health, judicial and consumer markets, and for licensing and integration.
The SOBRsafe technology is commercially available for point-of-care screening (SOBRcheck) and continuous monitoring (SOBRsure). At SOBRsafe, we are creating a culture of prevention and support. To learn more, visit www.sobrsafe.com.
Contact SOBRsafe:
IR@sobrsafe.com
Safe Harbor Statement
This announcement includes forward-looking statements within the meaning of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These statements are based on management's beliefs and assumptions, and on information currently available to management. Forward-looking statements include the information concerning our possible or assumed future results of operations set forth under the heading "Management's Discussion and Analysis of Financial Condition and Results of Operations." Forward-looking statements also include statements in which words such as "expect," "anticipate," "intend," "plan," "believe," "estimate," "consider," or similar expressions are used.
Forward-looking statements are not guarantees of future performance. They involve risks, uncertainties, and assumptions. Our future results and shareholder values may differ materially from those expressed in these forward-looking statements. Readers are cautioned not to put undue reliance on any forward-looking statements.
SOURCE: SOBR Safe, Inc.
View the original press release on accesswire.com
FAQ
What financial benefits did SOBRsafe gain from the recent warrant exercise?
What was the reduced exercise price for the warrants converted by SOBRsafe?
How many new warrants did SOBRsafe issue in the recent transaction?
What is the company ticker for SOBRsafe on Nasdaq?
What is the purpose of SOBRsafe's recent financial transactions?
